APVO logo

Aptevo Therapeutics (APVO) Net Income

Annual Net Income

-$17.41 M
-$25.44 M-316.91%

December 31, 2023


Summary


Performance

APVO Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPVOprofitabilitymetrics:

Quarterly Net Income

-$5.10 M
+$782.00 K+13.29%

September 30, 2024


Summary


Performance

APVO Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPVOprofitabilitymetrics:

TTM Net Income

-$23.72 M
+$1.23 M+4.94%

September 30, 2024


Summary


Performance

APVO TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPVOprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

APVO Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-316.9%+13.6%-36.2%
3 y3 years+1.9%+13.6%-36.2%
5 y5 years+67.6%+37.6%+41.4%

APVO Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-316.9%+38.8%-118.2%+35.8%-228.2%+17.9%
5 y5-year-316.9%+57.0%-118.2%+37.6%-228.2%+41.4%
alltimeall time-316.9%+84.5%-113.5%+92.9%-228.2%+79.4%

Aptevo Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.10 M(-13.3%)
-$23.72 M(-4.9%)
Jun 2024
-
-$5.88 M(-13.9%)
-$24.95 M(-7.6%)
Mar 2024
-
-$6.83 M(+15.8%)
-$27.02 M(+55.2%)
Dec 2023
-$17.41 M(-316.9%)
-$5.90 M(-6.8%)
-$17.41 M(+7.8%)
Sep 2023
-
-$6.33 M(-20.3%)
-$16.15 M(-7.5%)
Jun 2023
-
-$7.95 M(-386.6%)
-$17.46 M(-194.4%)
Mar 2023
-
$2.77 M(-159.7%)
$18.50 M(+130.4%)
Dec 2022
$8.03 M(-128.2%)
-$4.64 M(-39.3%)
$8.03 M(+25.5%)
Sep 2022
-
-$7.64 M(-127.3%)
$6.40 M(-9.2%)
Jun 2022
-
$28.01 M(-463.9%)
$7.04 M(-124.4%)
Mar 2022
-
-$7.70 M(+22.7%)
-$28.90 M(+1.5%)
Dec 2021
-$28.46 M(+60.3%)
-$6.27 M(-10.4%)
-$28.46 M(-2.7%)
Sep 2021
-
-$7.00 M(-11.8%)
-$29.24 M(+0.7%)
Jun 2021
-
-$7.93 M(+9.3%)
-$29.03 M(+4.0%)
Mar 2021
-
-$7.26 M(+2.9%)
-$27.90 M(+57.2%)
Dec 2020
-$17.75 M(-56.1%)
-$7.05 M(+3.9%)
-$17.75 M(-5.9%)
Sep 2020
-
-$6.79 M(-0.2%)
-$18.87 M(-0.7%)
Jun 2020
-
-$6.80 M(-334.8%)
-$19.00 M(-25.6%)
Mar 2020
-
$2.90 M(-135.4%)
-$25.53 M(-36.9%)
Dec 2019
-$40.45 M
-$8.17 M(+18.1%)
-$40.45 M(-12.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$6.92 M(-48.1%)
-$46.40 M(-10.8%)
Jun 2019
-
-$13.33 M(+10.9%)
-$52.04 M(+0.4%)
Mar 2019
-
-$12.02 M(-14.9%)
-$51.85 M(-3.4%)
Dec 2018
-$53.69 M(-870.0%)
-$14.13 M(+12.5%)
-$53.69 M(+8.9%)
Sep 2018
-
-$12.56 M(-4.4%)
-$49.32 M(-4547.2%)
Jun 2018
-
-$13.14 M(-5.1%)
$1.11 M(-63.8%)
Mar 2018
-
-$13.85 M(+41.9%)
$3.06 M(-56.1%)
Dec 2017
$6.97 M(-106.2%)
-$9.76 M(-125.8%)
$6.97 M(+290.2%)
Sep 2017
-
$37.87 M(-438.4%)
$1.79 M(-101.7%)
Jun 2017
-
-$11.19 M(+12.5%)
-$107.82 M(-1.5%)
Mar 2017
-
-$9.95 M(-33.5%)
-$109.47 M(-2.6%)
Dec 2016
-$112.42 M(+89.5%)
-$14.95 M(-79.2%)
-$112.41 M(-2.6%)
Sep 2016
-
-$71.74 M(+458.8%)
-$115.37 M(+104.9%)
Jun 2016
-
-$12.84 M(-0.4%)
-$56.30 M(-8.0%)
Mar 2016
-
-$12.89 M(-28.0%)
-$61.18 M(+3.1%)
Dec 2015
-$59.32 M(+16.0%)
-$17.90 M(+41.2%)
-$59.32 M(+43.2%)
Sep 2015
-
-$12.68 M(-28.4%)
-$41.42 M(+44.1%)
Jun 2015
-
-$17.72 M(+60.7%)
-$28.74 M(+160.7%)
Mar 2015
-
-$11.02 M
-$11.02 M
Dec 2014
-$51.12 M(-4.2%)
-
-
Dec 2013
-$53.34 M
-
-

FAQ

  • What is Aptevo Therapeutics annual net profit?
  • What is the all time high annual net income for Aptevo Therapeutics?
  • What is Aptevo Therapeutics annual net income year-on-year change?
  • What is Aptevo Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Aptevo Therapeutics?
  • What is Aptevo Therapeutics quarterly net income year-on-year change?
  • What is Aptevo Therapeutics TTM net profit?
  • What is the all time high TTM net income for Aptevo Therapeutics?
  • What is Aptevo Therapeutics TTM net income year-on-year change?

What is Aptevo Therapeutics annual net profit?

The current annual net income of APVO is -$17.41 M

What is the all time high annual net income for Aptevo Therapeutics?

Aptevo Therapeutics all-time high annual net profit is $8.03 M

What is Aptevo Therapeutics annual net income year-on-year change?

Over the past year, APVO annual net profit has changed by -$25.44 M (-316.91%)

What is Aptevo Therapeutics quarterly net profit?

The current quarterly net income of APVO is -$5.10 M

What is the all time high quarterly net income for Aptevo Therapeutics?

Aptevo Therapeutics all-time high quarterly net profit is $37.87 M

What is Aptevo Therapeutics quarterly net income year-on-year change?

Over the past year, APVO quarterly net profit has changed by +$802.00 K (+13.59%)

What is Aptevo Therapeutics TTM net profit?

The current TTM net income of APVO is -$23.72 M

What is the all time high TTM net income for Aptevo Therapeutics?

Aptevo Therapeutics all-time high TTM net profit is $18.50 M

What is Aptevo Therapeutics TTM net income year-on-year change?

Over the past year, APVO TTM net profit has changed by -$6.31 M (-36.23%)